Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 27, 2018
Reporting Period: Fiscal First Quarter ended August 31, 2018
This filing serves as a Regulation FD disclosure to furnish presentation slides regarding the company's fiscal first quarter performance.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached presentation slides (Exhibit 99.1) rather than the body of the 8-K report.
Material Changes
No material changes or comparative financial data are detailed in the text of this filing. The document acts solely as a vehicle to distribute the presentation materials.
Guidance, Outlook, and Management Commentary
Management Commentary: The filing references presentation slides discussing the fiscal first quarter results.
Legal Status of Information: The information in the attached slides is furnished pursuant to Item 7.01 and is explicitly not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the information is not subject to the liabilities under that Section and shall not be incorporated by reference into other filings under the Securities Act of 1933.
Investor Verification Checklist
- Review Exhibit 99.1 (Presentation dated September 27, 2018) for actual financial figures and operational details.
- Note that the presentation slides are not legally "filed" and carry different liability standards than the 8-K text itself.
- Verify the fiscal quarter end date of August 31, 2018, when comparing against other reporting periods.